As part of Pfizer Canada’s ongoing commitment to transform lives through the power of purpose-driven innovation, the Pfizer Canada Healthcare Hub brings together the best and brightest of Canada’s tech industry to champion better patient care.
The Healthcare Hub is driven in partnership with Communitech, a Canadian technology supercharger that facilitates collaboration between industry partners and a national network of startups and scale-ups.
Through this initiative, Pfizer Canada supports innovative solutions that meet the urgent needs of today while future-proofing for tomorrow.
How Does it Work?
Focusing on challenges to address critical healthcare needs, Pfizer Canada works with trusted partners in the startup community and beyond, providing access to industry insights and internal expertise, real use cases and the know-how to scale from concept to launch.
It is through thoughtful collaboration where we can be true accelerators for digital health solutions.
What’s Happening Now?
In October 2023, Pfizer Canada and Communitech announced the tech and innovation startup winners and their respective proposal submissions. These were selected from an open call to help address key challenges in healthcare:
CANImmunize (Ottawa, Ontario): A technology solution that helps healthcare providers navigate complex immunization guidelines to enhance both patient safety and the healthcare provider experience, ultimately improving vaccine awareness and uptake.
PharmaGuide (Richmond Hill, Ontario): An innovative patient portal, PharmaVision, that will use artificial intelligence (AI) to streamline the drug coverage processes – eventually predicting the coverage by an insurer, with the goal of promoting transparency, informed decision-making, and better patient care.
Wave View Imaging (Calgary, Alberta): A novel breast imaging medical device that could provide accessible, comfortable, and convenient breast imaging for women of all ages. The device will first deliver breast density assessments but has the potential to address a currently unmet clinical need for neoadjuvant treatment monitoring, allowing Oncologists to monitor tumour response in clinic.
Pfizer has committed to investing $1.4 million across this first cohort of Healthcare Hub partners. The backing from Pfizer ranges from in-kind support to significant business donations to help design, develop, manufacture, and scale their respective solutions.
These substantial investments reflect Pfizer’s goal of acting as a true accelerator for digital solutions that will bring a meaningful contribution to redefining healthcare in Canada.
For more updates as Pfizer Canada continues to accelerate digital solutions in patient care, follow us on LinkedIn, Facebook, X or YouTube.